Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David F Ransohoff

Showing results (61-70 of 102) with videos related to

Pageof 11
Sort By:
Lancet (London, England)|September 14, 2010
Flexible sigmoidoscopy to prevent colorectal cancerV Paul Doria-Rose, Chris Vinden, David F Ransohoff, et al.
Journal of the National Cancer Institute|February 8, 2022
Counting Advanced Precancerous Lesions as True Positives When Determining Colorectal Cancer Screening Test SpecificityUri Ladabaum, Timothy R Church, Ziding Feng, et al.
Gastrointestinal Endoscopy|June 2, 2009
Variation in polyp detection rates at screening colonoscopyThomas F Imperiale, Elizabeth A Glowinski, Beth E Juliar, et al.
Journal of Clinical Epidemiology|June 19, 2003
Adequacy of reporting race/ethnicity in clinical trials in areas of health disparitiesGiselle Corbie-Smith, Diane Marie M St George, Sandra Moody-Ayers, et al.
Annals of Internal Medicine|August 11, 2015
Derivation and Validation of a Scoring System to Stratify Risk for Advanced Colorectal Neoplasia in Asymptomatic Adults: A Cross-sectional StudyThomas F Imperiale, Patrick O Monahan, Timothy E Stump, et al.
The New England Journal of Medicine|December 24, 2004
Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk populationThomas F Imperiale, David F Ransohoff, Steven H Itzkowitz, et al.
BMJ (Clinical Research Ed.)|December 4, 2024
Direct-to-consumer tests: emerging trends are cause for concernEmma Grundtvig Gram, Tessa Copp, David F Ransohoff, et al.
The New England Journal of Medicine|September 19, 2008
Five-year risk of colorectal neoplasia after negative screening colonoscopyThomas F Imperiale, Elizabeth A Glowinski, Ching Lin-Cooper, et al.
Journal of the National Cancer Institute|September 2, 2016
Risk of Advanced Neoplasia Using the National Cancer Institute's Colorectal Cancer Risk Assessment ToolThomas F Imperiale, Menggang Yu, Patrick O Monahan, et al.
Annals of Internal Medicine|December 18, 2003
Using risk for advanced proximal colonic neoplasia to tailor endoscopic screening for colorectal cancerThomas F Imperiale, David R Wagner, Ching Y Lin, et al.
Pageof 11

Showing results (61-70 of 102) with videos related to

Sort By:
Pageof 11
Lancet (London, England)|September 14, 2010
Flexible sigmoidoscopy to prevent colorectal cancerV Paul Doria-Rose, Chris Vinden, David F Ransohoff, et al.
Journal of the National Cancer Institute|February 8, 2022
Counting Advanced Precancerous Lesions as True Positives When Determining Colorectal Cancer Screening Test SpecificityUri Ladabaum, Timothy R Church, Ziding Feng, et al.
Gastrointestinal Endoscopy|June 2, 2009
Variation in polyp detection rates at screening colonoscopyThomas F Imperiale, Elizabeth A Glowinski, Beth E Juliar, et al.
Journal of Clinical Epidemiology|June 19, 2003
Adequacy of reporting race/ethnicity in clinical trials in areas of health disparitiesGiselle Corbie-Smith, Diane Marie M St George, Sandra Moody-Ayers, et al.
Annals of Internal Medicine|August 11, 2015
Derivation and Validation of a Scoring System to Stratify Risk for Advanced Colorectal Neoplasia in Asymptomatic Adults: A Cross-sectional StudyThomas F Imperiale, Patrick O Monahan, Timothy E Stump, et al.
The New England Journal of Medicine|December 24, 2004
Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk populationThomas F Imperiale, David F Ransohoff, Steven H Itzkowitz, et al.
BMJ (Clinical Research Ed.)|December 4, 2024
Direct-to-consumer tests: emerging trends are cause for concernEmma Grundtvig Gram, Tessa Copp, David F Ransohoff, et al.
The New England Journal of Medicine|September 19, 2008
Five-year risk of colorectal neoplasia after negative screening colonoscopyThomas F Imperiale, Elizabeth A Glowinski, Ching Lin-Cooper, et al.
Journal of the National Cancer Institute|September 2, 2016
Risk of Advanced Neoplasia Using the National Cancer Institute's Colorectal Cancer Risk Assessment ToolThomas F Imperiale, Menggang Yu, Patrick O Monahan, et al.
Annals of Internal Medicine|December 18, 2003
Using risk for advanced proximal colonic neoplasia to tailor endoscopic screening for colorectal cancerThomas F Imperiale, David R Wagner, Ching Y Lin, et al.
Pageof 11